Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-02-20

Clinical Trial Update: Placebo Controlled Clinical Trial of the Postoperative Opioid Sparing Effects of Intraoperative Dexmedetomidine Infusion for Thoracic Surgery [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial assessing whether intraoperative dexmedetomidine infusion reduces postoperative opioid needs after thoracic surgery; results complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Pain | Phase 3 | Status: COMPLETED | Results posted: 2024-02-20